BioWorld BioWorld MedTech BioWorld Asia

BioWorld

Another COVID-19 casualty: Ose shutters phase III Tedopi trial in NSCLC despite positive interim analysis
DUBLIN – Ose Immunotherapeutics SA finds itself in the difficult place of hitting the primary endpoint of the first part of a phase III trial of Tedopi, a therapeutic...

More in BioWorld

BioWorld MedTech

FDA nod for ABM Respiratory Care’s Biwaze Cough system
Charleston, S.C.-based startup ABM Respiratory Care has received U.S. FDA clearance for its first product, an airway clearance system known as Biwaze Cough. The portable...

More in BioWorld MedTech

BioWorld Asia

Shionogi forms JV with Ping An to expand in China and targets immuno-oncology for next venture
BEIJING – Osaka-based Japanese infectious disease specialist Shionogi & Co. Ltd. said it will partner with Chinese insurance giant Ping An to establish a data-driven joint...

More in BioWorld Asia